Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.32 |
| ▸ | MVD | P53602 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2486177 | 0.86 | FABP3 (0.39) | TSHR | |
| SCHEMBL19586648 | 0.85 | LPAR3 (0.46) | PPARDLPAR3LPAR1LPAR2 | |
| SCHEMBL12677767 | 0.76 | LPAR3 (0.35) | BTN3A1LPAR3LPAR1LPAR2 | |
| SCHEMBL29442237 | 0.75 | LPAR3 (0.46) | LPAR3LPAR1LPAR2 | |
| SCHEMBL3342055 | 0.75 | TP53 (0.46) | — | |
| SCHEMBL31033283 | 0.73 | CYP3A4 (0.36) | TSHR | |
| SCHEMBL31033309 | 0.71 | ALDH1A1 (0.37) | TSHR | |
| SCHEMBL16681909 | 0.71 | LPAR3 (0.54) | LPAR3LPAR1LPAR2 | |
| SCHEMBL497177 | 0.70 | LPAR3 (0.46) | BTN3A1PPARDLPAR3LPAR1LPAR2 | |
| SCHEMBL497295 | 0.70 | BTN3A1 (0.40) | BTN3A1PPARDLPAR3LPAR1LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240166673-A1 | CRYSTALS | AEROMICS, INC. (US) | 2024-05-23 | — | — | US | disclosed |
| US-11725018-B2 | Crystals | AEROMICS, INC. (US) | 2023-08-15 | — | — | US | disclosed |
| US-20220204536-A1 | CRYSTALS | AEROMICS, INC. (US) | 2022-06-30 | — | — | US | disclosed |
| US-11117909-B2 | Crystals | AEROMICS, INC. (US) | 2021-09-14 | — | — | US | disclosed |
| CN-113272302-A | Antibiotic compounds, process for their manufacture, pharmaceutical compositions containing them and their use | 德彪药业国际股份公司 | 2021-08-17 | — | — | CN | disclosed |
| US-20190185496-A1 | CRYSTALS | AEROMICS, INC. (US) | 2019-06-20 | — | — | US | disclosed |
| EP-3454846-A1 | CRYSTALS | Aeromics, Inc. (US) | 2019-03-20 | — | — | EP | disclosed |
| CN-109475516-A | Crystal | 埃罗米克斯公司 | 2019-03-15 | — | — | CN | disclosed |
| WO-2017197371-A1 | CRYSTALS | AEROMICS, INC. (US) | 2017-11-16 | — | — | WO | disclosed |
| US-7235666-B2 | Sulfonation of 3-(hydroxymethyl)-5,5-diphenylimidazolidine-2,4-dione followed by phosphating in the presence of trisubstituted aliphatic amine base and a polar aprotic solvent; anticonvulsants, antiepileptic and antiarrhythmia agent | CILAG LTD. (CH) | 2007-06-26 | — | — | US | disclosed |
| US-20050272706-A1 | Process for the preparation of sodium fosphenytoin | CILAG, LTD. | 2005-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272706-A1 | Process for the preparation of sodium fosphenytoin | FOS, DUSP5, DCPS | BTN3A1 4160/4885PPARD 2306/4885LPAR3 3350/4885 |
| US-20220204536-A1 | CRYSTALS | MTAP, PLCG2, PLCG1 | BTN3A1 3781/4885PPARD 2747/4885LPAR3 2119/4885 |
| US-20190185496-A1 | CRYSTALS | MTAP, PLCG2, PLCG1 | BTN3A1 3781/4885PPARD 2747/4885LPAR3 2119/4885 |
| US-11725018-B2 | Crystals | MTAP, PLCG2, PLCG1 | BTN3A1 3781/4885PPARD 2747/4885LPAR3 2119/4885 |
| US-20240166673-A1 | CRYSTALS | MTAP, PLCG2, PLCG1 | BTN3A1 3781/4885PPARD 2747/4885LPAR3 2119/4885 |
| US-11117909-B2 | Crystals | MTAP, PLCG2, PLCG1 | BTN3A1 3781/4885PPARD 2747/4885LPAR3 2119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.